Immunotherapy in Prostate Cancer
Journal Title: Üroonkoloji Bülteni - Year 2019, Vol 18, Issue 2
Abstract
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (FDA) approval of sipuleucel-T for asymptomatic or minimal symptomatic metastatic castration-resistant prostate cancer (CRPC). Despite all these developments, the patients in whom these agents should be used, sequential use and combination strategies remain unclear. In this review, mechanisms of action and survival outcomes of different immunotherapeutic agents and therapeutic cancer vaccines in mCRPC are discussed.
Authors and Affiliations
Deniz Bolatq, Ayfer Haydaroğlu
Keywords
Related Articles
- EP ID EP588916
- DOI 10.4274/uob.galenos.2018.1142
- Views 103
- Downloads 0
Is Preoperative Neutrophil Lymphocyte Ratio a Reliable Prognostic Parameter for Localized Prostate Cancer?
Objective In spite of all efforts, prostate cancer is still the 2nd highest cause of cancer-related deaths in men. For this reason new developments are needed in diagnosis, treatment and follow-up of prostate cancer. Neu...
Prostate and Bladder Metastases of Malignant Melanoma: Case Report
Prostate or bladder metastases of malignant melanoma (MM) are rarely encountered in clinical practice. To our knowledge, coexistence of prostate and bladder metastasis of MM has not been reported to date. We present the...
Evaluation of the Relationship between Pathology Results and Pain Scores in Patients Who Underwent Transrectal Ultrasound-Guided Prostate
Objectives: In this study, we assessed the relationship between pain scores and the pathology results of patients who underwent transrectal ultrasound-guided prostate biopsy (TRUS-PBx). Materials and Methods: A total of...
Should We Perform Thoracic Imaging for Every Patient with a Renal Mass?
Objective: Current guidelines for the management of renal mass recommend thoracic imaging for potential metastatic nodules. Small size of the renal mass can be associated with low metastatic potential, which might questi...
Risk Factors for Adrenal Invasion in Renal Cell Carcinoma
Objective: In this study, we aimed to describe the risk factors associated with adrenal invasion in patients who were diagnosed with renal cell carcinoma (RCC) after radical nephrectomy and identify which risk factors ar...